|
1
|
Kwon HJ, Lee S, Han YB, Lee J, Kwon S, Kim
H and Chung JH: Genomic landscape of pulmonary sarcomatoid
carcinoma. Cancer Res Treat. 56:442–454. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liang X, Cheng Y, Yuan Z, Li Q, Huang Y
and Feng G: Clinical, pathological and treatment factors associated
with the survival of patients with pulmonary sarcomatoid carcinoma.
Oncol Lett. 19:4031–4039. 2020.PubMed/NCBI
|
|
3
|
Oi H, Taki T, Kuroe T, Sakamoto N,
Sakashita S, Kojima M, Sugiyama E, Umemura S, Sakai T, Izumi H, et
al: NETosis in pulmonary pleomorphic carcinoma. Cancer Sci.
116:524–532. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen Z, Liu J and Min L:
Clinicopathological characteristics, survival outcomes and
prognostic factors in pleomorphic carcinoma: A SEER
population-based study. BMC Pulm Med. 22:1162022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wei Y, Wang L, Jin Z, Jia Q, Brcic L,
Akaba T and Chu Q: Biological characteristics and clinical
treatment of pulmonary sarcomatoid carcinoma: A narrative review.
Transl Lung Cancer Res. 13:635–653. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim C, Cho HH, Choi JY, Franks TJ, Han J,
Choi Y, Lee SH, Park H and Lee KS: Pleomorphic carcinoma of the
lung: Prognostic models of semantic, radiomics and combined
features from CT and PET/CT in 85 patients. Eur J Radiol Open.
8:1003512021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yamakawa H, Yoshida M, Yabe M, Baba Y,
Baba E, Katagi H, Ishikawa T, Takagi M, Nakada T, Akiba T and
Kuwano K: Pulmonary pleomorphic carcinoma detected as a result of
pneumothorax and the subsequent occurrence of multiple cystic
metastases. Case Rep Med. 2014:2192732014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang Y, Mei J and Lin F: Pleomorphic
carcinoma of the lung: From thin-walled cavity to solid tumor. Ann
Transl Med. 7:2732019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Iwamura M, Nishimori M, Iwasa H, Otani M,
Nakaji K, Nitta N, Miyatake K, Yoshimatsu R, Yamanishi T, Matsumoto
T, et al: A case of pulmonary pleomorphic carcinoma associated with
cystic airspace. Radiol Case Rep. 18:2692–2696. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lai RS, Perng RP and Chang SC: Primary
lung cancer complicated with pneumothorax. Jpn J Clin Oncol.
22:194–197. 1992.PubMed/NCBI
|
|
11
|
Li X, Wu D, Liu H and Chen J: Pulmonary
sarcomatoid carcinoma: Progress, treatment and expectations. Ther
Adv Med Oncol. 12:17588359209502072020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sindhu RK, Verma R, Salgotra T, Rahman MH,
Shah M, Akter R, Murad W, Mubin S, Bibi P, Qusti S, et al:
Impacting the remedial potential of nano delivery-based flavonoids
for breast cancer treatment. Molecules. 26:51632021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zeng Q, Li J, Sun N, Xue Q, Gao Y, Zhao J,
Mao Y, Mu J, Wang D, Gao S and He J: Preoperative systemic
immune-inflammation index predicts survival and recurrence in
patients with resected primary pulmonary sarcomatoid carcinoma.
Transl Lung Cancer Res. 10:18–31. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ferhatoglu F, Amirov F, Ozkan B, Kara M,
Toker A, Ak N, Aydın E, Paksoy N, Yilmazbayhan D and Aydiner A:
Clinicopathological and prognostic features of 67 cases with
pulmonary sarcomatoid carcinoma: An 18-year single-centre
experience. Oncol Res Treat. 44:590–601. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Batchelor TJP: Commentary: Resected
pulmonary sarcomatoid carcinoma-a defined treatment paradigm, or
just the end of the beginning of the search? J Thorac Cardiovasc
Surg. 163:1683–1684. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Schrock AB, Li SD, Frampton GM, Suh J,
Braun E, Mehra R, Buck SC, Bufill JA, Peled N, Karim NA, et al:
Pulmonary sarcomatoid carcinomas commonly harbor either potentially
targetable genomic alterations or high tumor mutational burden as
observed by comprehensive genomic profiling. J Thorac Oncol.
12:932–942. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang F, Daylan AE, Deng L, Yang J, Sharma
J, Su C, Li S, Zang X, Halmos B, Borczuk A and Cheng H:
Heterogeneous expression of PD-L1, B7×, B7-H3, and HHLA2 in
pulmonary sarcomatoid carcinoma and the related regulatory
signaling pathways. Cancers (Basel). 15:33722023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mendoza DP, Heeger A, Mino-Kenudson M,
Lanuti M, Shepard JO, Sequist LV and Digumarthy SR:
Clinicopathologic and longitudinal imaging features of lung cancer
associated with cystic airspaces: A systematic review and
meta-analysis. AJR Am J Roentgenol. 216:318–329. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang K, Leng X, Yi H, Zhang G, Hu Z and
Mao Y: Lung cancer associated with cystic airspaces: Current
insights into diagnosis, pathophysiology, and treatment strategies.
Cancers (Basel). 16:39302024. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu L, Lou Y and Zhu D: A case of
adenocarcinoma presenting with cystic lesion and recurrent
pneumothoraces. J Cardiothorac Surg. 19:5762024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sheard S, Moser J, Sayer C, Stefanidis K,
Devaraj A and Vlahos I: Lung cancers associated with cystic
airspaces: Underrecognized features of early disease.
Radiographics. 38:704–717. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Saad HM, Tourky GF, Al-Kuraishy HM,
Al-Gareeb AI, Khattab AM, Elmasry SA, Alsayegh AA, Hakami ZH,
Alsulimani A, Sabatier JM, et al: The potential role of MUC16
(CA125) biomarker in lung cancer: A magic biomarker but with
adversity. Diagnostics (Basel). 12:29852022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Brunelli A, Charloux A, Bolliger CT, Rocco
G, Sculier JP, Varela G, Licker M, Ferguson MK, Faivre-Finn C,
Huber RM, et al: ERS/ESTS clinical guidelines on fitness for
radical therapy in lung cancer patients (surgery and
chemo-radiotherapy). Eur Respir J. 34:17–41. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Brunelli A, Kim AW, Berger KI and
Addrizzo-Harris DJ: Physiologic evaluation of the patient with lung
cancer being considered for resectional surgery: Diagnosis and
management of lung cancer, 3rd ed: American College of Chest
Physicians evidence-based clinical practice guidelines. Chest. 145
(5 Suppl):e166S–e190S. 2014.
|
|
25
|
Fennelly J, Potter L, Pompili C and
Brunelli A: Performance in the shuttle walk test is associated with
cardiopulmonary complications after lung resections. J Thorac Dis.
9:789–795. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lunxu L, Shugeng G, Jianxing H, Jian H, Di
G, Hecheng L, Mingqiang K, Fengwei T and Kaican C; Chinese
Association of Thoracic Surgeons, : Thoracic Surgery Society of
China Medicine Education Association: Chinese thoracic surgery
experts consensus on postoperative follow-up plans for non-small
cell lung cancer patients. Chinese J Clinical Thoracic and
Cardiovascular Surgery. 28:4–10. 2021.
|
